This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Leland Stanford Junior University, Oregon Health & Science University. Active years: 2020.
Company Filing History:
1 out of 5,497 
1 out of 524 
Years Active: 2020
Title: Nancy Meyer: Innovator in AAV Infection Modulation
Introduction
Nancy Meyer is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of molecular biology, particularly in the modulation of adeno-associated virus (AAV) infection. Her innovative work has implications for gene therapy and other biotechnological applications.
Latest Patents
Nancy Meyer holds 1 patent titled "Methods and compositions for modulating AAV infection." This patent provides compositions and methods for enhancing or reducing the permissiveness of target cells to AAV infection. The methods include increasing levels of AAVR (KIAA0319L) in the cell to enhance infection or reducing AAVR levels to decrease infection. Additionally, the patent outlines techniques for nucleic acid delivery by utilizing AAV particles.
Career Highlights
Throughout her career, Nancy Meyer has worked with esteemed institutions such as Oregon Health & Science University and Leland Stanford Junior University. Her research has focused on advancing the understanding of viral infections and developing innovative solutions for gene delivery.
Collaborations
Nancy has collaborated with notable colleagues, including Sirika Pillay and Jan E Carette. These partnerships have contributed to her research and the advancement of her patented technologies.
Conclusion
Nancy Meyer is a key figure in the field of AAV infection modulation, with her patent offering valuable insights and methods for enhancing gene therapy applications. Her work continues to influence the landscape of molecular biology and biotechnology.